Neuroleptic Malignant Syndrome

The researchers theorized that this increased effectiveness was due not to “antidepressant” properties, but rather to the drug’s side effects, which include insomnia, drowsiness, and nausea.

A recent RCT showed that vitamin B6 is as effective as propranolol for the treatment of akathisia.

Sir Robin Murray, a professor at the Institute of Psychiatry, Psychology, and Neuroscience in London, states that he ignored social factors that contribute to ‘schizophrenia’ for too long. He also reports that he neglected the negative effects antipsychotic medication has on the brain.

Despite little evidence for benefit, and substantial risk of harm, antipsychotics are commonly prescribed to children diagnosed with ADHD

A new special issue brings together articles exploring the harmful effects of simultaneous multiple medication use.

A large review and meta-analysis of 167 studies across 60 years dissects placebo-controlled randomized controlled trials of antipsychotic drugs.

A new study has found that children and adolescents taking a high dose of antipsychotics are almost twice as likely to die of any cause than children on other types of medications.

New study confirms previous evidence that antidepressant use is linked to developing type 2 diabetes.

People who reduced antipsychotic use by tapering were doing just as well after five years as those who continued using the drugs.

Increased Parkinson's risk could be related to lithium, antipsychotic, and antiepileptic drug use.

A new study published this month in the journal Neuron identifies the mechanism by which antipsychotic drugs can induce parkinsonism, a condition involving movement...

How does physical activity affect people diagnosed with bipolar, schizophrenia and major depressive disorders?

Research from London and Taipei finds that neuroleptic malignant syndrome (NMS) is associated with the number of different antipsychotics used (polypharmacy), rather than the overall...

In a study published yesterday, researchers from the Nippon Medical School in Tokyo bring attention to a condition known as neuroleptic-induced deficit syndrome (NIDS)...

Researchers from the City College of New York and Columbia University published a study this month testing the hypothesis that people diagnosed with schizophrenia treated long-term with antipsychotic drugs have worse outcomes than patients with no exposure to these drugs. They concluded that there is not a sufficient evidence base for the standard practice of long-term use of antipsychotic medications.

Analysis of longitudinal data from 2000-2014 demonstrate mortality gap is widening between persons with a diagnosis of bipolar or schizophrenia compared to the general population

Despite the fact that clinical practice guidelines specifically recommend against the use of more than one antipsychotic at once, new research reveals that as...

Patients who recover from a single episode of psychosis are often prescribed antipsychotics long-term, despite a lack of evidence for this practice

In a featured article for Psychiatric Services, psychiatrists from Dartmouth raise the alarm on the increasing numbers of children prescribed dangerous antipsychotic drugs. Despite the fact that data on the safety of long-term use of these drugs in this vulnerable population “do not exist,” the rate of children and adolescents being prescribed antipsychotic drugs have continued to increase over the past fifteen years.

Researchers reveal the limitations and misleading interpretations of two recent studies that claim to demonstrate that long-term antipsychotic use leads to better outcomes.

Review study compares outcomes of gradual vs. immediate antipsychotic discontinuation when switching from one drug to another.

Antipsychotics present a known risk for major side effects. A new study suggests that certain antipsychotics may present a greater risk for cardiovascular disease than others.

Researchers believe that side-effect monitoring is critical because of the increase in the use of antipsychotics

On November 12th, 2015, the third anniversary of the day that I abruptly stopped taking benzodiazepines, my dear friend, J. Doe, published a two-part article here on Mad in America examining the language that is commonly used to describe benzodiazepine (benzo) iatrogenesis. I wanted a summary of these articles captured in a Youtube video so that those in the thick of benzo neurotoxicity could tune into these ideas in a way that might be more easily digestible. I hoped more benzo sufferers would begin to question how they describe (and allow others to describe) an illness that remains decades behind in understanding and recognition. I also wanted to draw attention to the content again in hopes that more medical professionals would read and understand the crucial distinctions in language surrounding this problem.

When I was born, everyone was expecting me to have arms. The doctor's mind raced; how am I going to tell this mother and the father that their son has hands but not arms? If he's missing so much in his extremities, mustn’t he also be missing a mind? My mom looked into my eyes and knew - in a way that only mothers know - that I had a mind, and spirit.